Matthias Schulze, Merck<\/em><\/p>\n Introduction of Merck\u2019s capabilities to supply specifically labeled tracers in different grades. Matthias Schulze studied chemistry at the TU Berlin and gained his PhD in 1991 for research in natural product synthesis. Subsequent stays at various sites abroad (Norman, Oklahoma and Columbus, Ohio) extended his expertise in analytical and synthetical techniques. Later, he worked as a group leader at the University Bonn on mechanistic questions in metal-organic chemistry and new ways to access cyclic natural products. He has 20 years of experience in stable isotopes and its applications in a corporate environment. His current role is that of a technology manager for stable isotopes in EMEA. Ever since he worked with numerous researchers to support them in a broad range of fields, focusing on biochemical and medicinal topics<\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":"
\nDescribing the milestones of DNP towards establishing that method as a powerful tool in cancer diagnostics. Outlining the challenges and the scope on projects utilizing 13 C labeled reagents.<\/p>\n
\n